Regulation of Lymphocyte Development by HLH Proteins
HLH 蛋白对淋巴细胞发育的调节
基本信息
- 批准号:8638491
- 负责人:
- 金额:$ 38.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-01-15 至 2018-12-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAllelesApplications GrantsB-LymphocytesBiological AssayBone MarrowCell LineageCell MaturationCell SurvivalCell physiologyCellsCommitDataDendritic CellsDevelopmentE proteinEffector CellEventFailureGene DeletionGene ExpressionGenesGenetic TranscriptionGoalsGranzymeHelix-Turn-Helix MotifsITGAM geneImmuneImmune responseImmune systemImmunologic MemoryImmunotherapyIn VitroInflammatoryInterventionLymphocyteLymphoidMaintenanceMalignant - descriptorMalignant NeoplasmsMemoryModelingMolecularMultipotent Stem CellsMusNatural Killer CellsOutcomePlayPopulationProcessProductionProteinsRegulationResearchRoleSignal PathwaySignaling ProteinSpecific qualifier valueStressT cell differentiationT-Cell DevelopmentT-Lymphocyte SubsetsTCF3 geneTamoxifenTestingTherapeuticTherapeutic InterventionTransplantationVirusVirus Diseasesadaptive immunitybasecancer cellcancer immunotherapycell transformationcytokinegene functionhelix-loop-helix protein differentiation inhibitorin vivoinhibitor/antagonistinsightkillingsleukemogenesismRNA Expressionnovelpreventprogenitorprotein Eprotein expressionprotein functionpublic health relevancerecombinaseresearch studyresponsetranscription factortumor
项目摘要
Project Summary
Natural killer (NK) cells play an important role in the immune response to viral infection
and in the eradication of stressed or transformed cells. They can also influence adaptive
immune responses through production of inflammatory cytokines and modulation of
dendritic cell function. Their ability to kill transformed cells and influence adaptive
immunity has made them an attractive candidate for tumor immunotherapy. However,
our understanding of the mechanisms controlling NK cell development and function are
inadequate to allow us to predict the outcome of therapeutic manipulations on NK cell
response. My research is focused on understanding the molecular mechanisms
controlling innate and adaptive lymphocyte development with an emphasis on the E
protein helix-loop-helix transcription factors and their antagonists that Id proteins. Id2 is
critical for NK cell development but how it functions and whether it is required for proper
NK cell maturation and function has remained elusive We will test the hypothesis that
Id2 is required for the terminal maturation of mature (m)NK cells and therefore influences
the response of NK cells to virus infection thus limiting immunologic memory in the NK
cell population. We hypothesize that Id2 functions to limit E protein activity sufficiently to
restrain their potential for differentiation toward alternative lymphocyte fates yet allows E
proteins to activate a subset of T cell-associated signaling proteins that are required in a
subset of mNK cells. We will determine the molecular mechanism by which the E
proteins, which are inhibited by Id2, function to alter the fate and function of NK lineage
cells. Our studies will allow us to place the functions of E proteins and Id2 into the larger
network of transcriptional regulators that control NK cell development and function and
will contribute to our understanding of how therapeutic interventions will influence NK
cell responses.
项目摘要
自然杀伤(NK)细胞在病毒感染的免疫应答中起重要作用
以及根除应激或转化细胞。它们也会影响适应性
通过产生炎性细胞因子和调节
树突状细胞功能它们杀死转化细胞并影响适应性的能力
免疫性使它们成为肿瘤免疫治疗的有吸引力的候选者。然而,在这方面,
我们对控制NK细胞发育和功能的机制的理解是
不足以让我们预测NK细胞治疗操作的结果
反应我的研究重点是了解
控制先天性和适应性淋巴细胞发育,重点是E
蛋白螺旋-环-螺旋转录因子及其Id蛋白的拮抗剂。Id 2是
NK细胞发育的关键,但它如何发挥作用,以及是否需要适当的
NK细胞的成熟和功能仍然难以捉摸。
Id 2是成熟(m)NK细胞的终末成熟所需的,因此影响
NK细胞对病毒感染的反应,从而限制了NK细胞中的免疫记忆,
细胞群我们假设Id 2的功能是充分限制E蛋白的活性,
抑制其向备选淋巴细胞命运分化的潜力,但允许E
蛋白质激活T细胞相关信号蛋白的子集,这些信号蛋白是免疫应答中所需的。
mNK细胞亚群。我们将确定E
受Id 2抑制的蛋白质起改变NK谱系的命运和功能的作用
细胞我们的研究将使我们能够将E蛋白和Id 2的功能置于更大的
控制NK细胞发育和功能的转录调节因子网络,
将有助于我们了解治疗干预如何影响NK细胞
细胞反应。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BARBARA L. KEE其他文献
BARBARA L. KEE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BARBARA L. KEE', 18)}}的其他基金
Investigating Helios as a regulator of natural killer cell effector maturation
研究 Helios 作为自然杀伤细胞效应成熟的调节剂
- 批准号:
10608673 - 财政年份:2023
- 资助金额:
$ 38.39万 - 项目类别:
Identification of BATF function and targets during NK cell activation
NK 细胞激活过程中 BATF 功能和靶标的鉴定
- 批准号:
10494220 - 财政年份:2021
- 资助金额:
$ 38.39万 - 项目类别:
Identification of BATF function and targets during NK cell activation
NK 细胞激活过程中 BATF 功能和靶标的鉴定
- 批准号:
10354363 - 财政年份:2021
- 资助金额:
$ 38.39万 - 项目类别:
Mechanisms of E protein transcription factor-dependent iNKT cell expansion and differentiation
E蛋白转录因子依赖性iNKT细胞扩增和分化的机制
- 批准号:
9242168 - 财政年份:2016
- 资助金额:
$ 38.39万 - 项目类别:
Mechanisms of E protein transcription factor-dependent iNKT cell expansion and differentiation
E蛋白转录因子依赖性iNKT细胞扩增和分化的机制
- 批准号:
10065488 - 财政年份:2016
- 资助金额:
$ 38.39万 - 项目类别:
Molecular Mechanisms of Invariant Natural Killer T Cell Differentiation
恒定自然杀伤T细胞分化的分子机制
- 批准号:
10627307 - 财政年份:2016
- 资助金额:
$ 38.39万 - 项目类别:
Analysis of the role of immune deficiency in E2A-/- T cell lymphomagenesis
免疫缺陷在E2A-/- T细胞淋巴瘤发生中的作用分析
- 批准号:
8959799 - 财政年份:2015
- 资助金额:
$ 38.39万 - 项目类别:
EZH2 in lymphoid lineage specification and commitment
EZH2 淋巴谱系规范和承诺
- 批准号:
8622415 - 财政年份:2014
- 资助金额:
$ 38.39万 - 项目类别:
Transcriptional Control of Natural Killer Cell Development
自然杀伤细胞发育的转录控制
- 批准号:
10540688 - 财政年份:2014
- 资助金额:
$ 38.39万 - 项目类别:
Regulation of Lymphocyte Development by HLH Proteins
HLH 蛋白对淋巴细胞发育的调节
- 批准号:
8791299 - 财政年份:2014
- 资助金额:
$ 38.39万 - 项目类别:
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 38.39万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 38.39万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 38.39万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 38.39万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 38.39万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 38.39万 - 项目类别:
Studentship
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 38.39万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 38.39万 - 项目类别:
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 38.39万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 38.39万 - 项目类别: